You’re reading Entrepreneur United States, an international franchise of Entrepreneur Media. This story originally appeared on Zacks

In the latest trading session, Union Pacific (UNP) closed at $211.88, marking a -0.26% move from the previous day. This change lagged the S&P 500’s 0.83% gain on the day.

Heading into today, shares of the railroad had lost 1.31% over the past month, outpacing the Transportation sector’s loss of 4.84% and the S&P 500’s loss of 3.68% in that time.

UNP will be looking to display strength as it nears its next earnings release, which is expected to be October 21, 2021. The company is expected to report EPS of $2.52, up 25.37% from the prior-year quarter. Our most recent consensus estimate is calling for quarterly revenue of $5.53 billion, up 12.47% from the year-ago period.

UNP’s full-year Zacks Consensus Estimates are calling for earnings of $9.93 per share and revenue of $21.6 billion. These results would represent year-over-year changes of +21.25% and +10.58%, respectively.

Any recent changes to analyst estimates for UNP should also be noted by investors. These revisions typically reflect the latest short-term business trends, which can change frequently. As such, positive estimate revisions reflect analyst optimism about the company’s business and profitability.

Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.

The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 0.87% lower within the past month. UNP currently has a Zacks Rank of #4 (Sell).

Looking at its valuation, UNP is holding a Forward P/E ratio of 21.39. This represents a discount compared to its industry’s average Forward P/E of 21.96.

It is also worth noting that UNP currently has a PEG ratio of 2.14. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company’s expected earnings growth rate. Transportation – Rail stocks are, on average, holding a PEG ratio of 2.14 based on yesterday’s closing prices.

The Transportation – Rail industry is part of the Transportation sector. This group has a Zacks Industry Rank of 229, putting it in the bottom 10% of all 250+ industries.

The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

You can find more information on all of these metrics, and much more, on Zacks.com.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $2.4 trillion by 2028 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Recommendations from previous editions of this report have produced gains of +205%, +258% and +477%. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Union Pacific Corporation (UNP): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

You’re reading Entrepreneur United States, an international franchise of Entrepreneur Media. This story originally appeared on Zacks

In the latest trading session, Ternium S.A. (TX) closed at $42.42, marking a +1.9% move from the previous day. This change outpaced the S&P 500’s 0.83% gain on the day.

Heading into today, shares of the company had lost 22.32% over the past month, lagging the Basic Materials sector’s loss of 7.98% and the S&P 500’s loss of 3.68% in that time.

Wall Street will be looking for positivity from TX as it approaches its next earnings report date. This is expected to be November 2, 2021. On that day, TX is projected to report earnings of $4.62 per share, which would represent year-over-year growth of 657.38%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $4.1 billion, up 91.84% from the year-ago period.

For the full year, our Zacks Consensus Estimates are projecting earnings of $16.93 per share and revenue of $15.54 billion, which would represent changes of +460.6% and +77.91%, respectively, from the prior year.

Investors should also note any recent changes to analyst estimates for TX. These revisions typically reflect the latest short-term business trends, which can change frequently. As such, positive estimate revisions reflect analyst optimism about the company’s business and profitability.

Our research shows that these estimate changes are directly correlated with near-term stock prices. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.

The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. TX is currently a Zacks Rank #1 (Strong Buy).

Looking at its valuation, TX is holding a Forward P/E ratio of 2.46. For comparison, its industry has an average Forward P/E of 4.29, which means TX is trading at a discount to the group.

Meanwhile, TX’s PEG ratio is currently 0.13. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company’s expected earnings growth rate into account. The Steel – Producers was holding an average PEG ratio of 0.17 at yesterday’s closing price.

The Steel – Producers industry is part of the Basic Materials sector. This industry currently has a Zacks Industry Rank of 40, which puts it in the top 16% of all 250+ industries.

The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Make sure to utilize Zacks. Com to follow all of these stock-moving metrics, and more, in the coming trading sessions.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $2.4 trillion by 2028 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Recommendations from previous editions of this report have produced gains of +205%, +258% and +477%. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Ternium S.A. (TX): Free Stock Analysis Report
 
To read this article on Zacks.com click here.

You’re reading Entrepreneur United States, an international franchise of Entrepreneur Media. This story originally appeared on Zacks

In the latest trading session, Toyota Motor Corporation (TM) closed at $169.47, marking a +1.5% move from the previous day. This change outpaced the S&P 500’s 0.83% gain on the day.

Coming into today, shares of the company had lost 7.24% in the past month. In that same time, the Auto-Tires-Trucks sector lost 3.1%, while the S&P 500 lost 3.68%.

TM will be looking to display strength as it nears its next earnings release. In that report, analysts expect TM to post earnings of $3.16 per share. This would mark year-over-year growth of 0.32%. Meanwhile, our latest consensus estimate is calling for revenue of $67.23 billion, up 5.32% from the prior-year quarter.

TM’s full-year Zacks Consensus Estimates are calling for earnings of $13.55 per share and revenue of $289.92 billion. These results would represent year-over-year changes of -9.61% and +12.71%, respectively.

It is also important to note the recent changes to analyst estimates for TM. These recent revisions tend to reflect the evolving nature of short-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company’s business outlook.

Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.

Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Within the past 30 days, our consensus EPS projection has moved 32.76% lower. TM is currently sporting a Zacks Rank of #3 (Hold).

In terms of valuation, TM is currently trading at a Forward P/E ratio of 12.32. This represents a premium compared to its industry’s average Forward P/E of 11.02.

Also, we should mention that TM has a PEG ratio of 0.57. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company’s expected earnings growth rate into account. The Automotive – Foreign was holding an average PEG ratio of 0.45 at yesterday’s closing price.

The Automotive – Foreign industry is part of the Auto-Tires-Trucks sector. This group has a Zacks Industry Rank of 117, putting it in the top 47% of all 250+ industries.

The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

To follow TM in the coming trading sessions, be sure to utilize Zacks.com.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $2.4 trillion by 2028 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Recommendations from previous editions of this report have produced gains of +205%, +258% and +477%. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Toyota Motor Corporation (TM): Free Stock Analysis Report
 
To read this article on Zacks.com click here.

You’re reading Entrepreneur United States, an international franchise of Entrepreneur Media. This story originally appeared on Zacks

In the latest trading session, Roblox (RBLX) closed at $74.80, marking a +1.49% move from the previous day. The stock outpaced the S&P 500’s daily gain of 0.83%.

Coming into today, shares of the online gaming platform had lost 11.75% in the past month. In that same time, the Consumer Discretionary sector lost 4.98%, while the S&P 500 lost 3.68%.

Wall Street will be looking for positivity from RBLX as it approaches its next earnings report date.

Investors might also notice recent changes to analyst estimates for RBLX. These recent revisions tend to reflect the evolving nature of short-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company’s business outlook.

Based on our research, we believe these estimate revisions are directly related to near-team stock moves. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.

The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 0.74% lower. RBLX is currently a Zacks Rank #3 (Hold).

The Gaming industry is part of the Consumer Discretionary sector. This group has a Zacks Industry Rank of 180, putting it in the bottom 30% of all 250+ industries.

The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $2.4 trillion by 2028 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Recommendations from previous editions of this report have produced gains of +205%, +258% and +477%. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Roblox Corporation (RBLX): Free Stock Analysis Report
 
To read this article on Zacks.com click here.

You’re reading Entrepreneur United States, an international franchise of Entrepreneur Media. This story originally appeared on Zacks

In the latest trading session, Petrobras (PBR) closed at $10.64, marking a -0.37% move from the previous day. This change lagged the S&P 500’s 0.83% gain on the day.

Coming into today, shares of the oil and gas company had gained 9.54% in the past month. In that same time, the Oils-Energy sector gained 9.14%, while the S&P 500 lost 3.68%.

PBR will be looking to display strength as it nears its next earnings release. On that day, PBR is projected to report earnings of $0.61 per share, which would represent year-over-year growth of 577.78%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $22.25 billion, up 69.21% from the year-ago period.

Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of $2.33 per share and revenue of $79.71 billion. These totals would mark changes of +441.86% and +48.48%, respectively, from last year.

Investors might also notice recent changes to analyst estimates for PBR. These revisions typically reflect the latest short-term business trends, which can change frequently. As a result, we can interpret positive estimate revisions as a good sign for the company’s business outlook.

Our research shows that these estimate changes are directly correlated with near-term stock prices. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.

The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. PBR is holding a Zacks Rank of #3 (Hold) right now.

In terms of valuation, PBR is currently trading at a Forward P/E ratio of 4.58. Its industry sports an average Forward P/E of 5.8, so we one might conclude that PBR is trading at a discount comparatively.

Meanwhile, PBR’s PEG ratio is currently 0.22. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company’s expected earnings growth rate. The Oil and Gas – Integrated – Emerging Markets industry currently had an average PEG ratio of 0.22 as of yesterday’s close.

The Oil and Gas – Integrated – Emerging Markets industry is part of the Oils-Energy sector. This industry currently has a Zacks Industry Rank of 65, which puts it in the top 26% of all 250+ industries.

The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

You can find more information on all of these metrics, and much more, on Zacks.com.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $2.4 trillion by 2028 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Recommendations from previous editions of this report have produced gains of +205%, +258% and +477%. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Petroleo Brasileiro S.A. Petrobras (PBR): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

You’re reading Entrepreneur United States, an international franchise of Entrepreneur Media. This story originally appeared on Zacks

Morgan Stanley (MS) closed at $98.80 in the latest trading session, marking a -0.3% move from the prior day. This change lagged the S&P 500’s daily gain of 0.83%.

Prior to today’s trading, shares of the investment bank had lost 4.32% over the past month. This has lagged the Finance sector’s loss of 1.34% and the S&P 500’s loss of 3.68% in that time.

Investors will be hoping for strength from MS as it approaches its next earnings release, which is expected to be October 14, 2021. In that report, analysts expect MS to post earnings of $1.70 per share. This would mark year-over-year growth of 6.92%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $13.85 billion, up 18.82% from the year-ago period.

For the full year, our Zacks Consensus Estimates are projecting earnings of $7.56 per share and revenue of $57.79 billion, which would represent changes of +14.89% and +19.9%, respectively, from the prior year.

Any recent changes to analyst estimates for MS should also be noted by investors. These revisions help to show the ever-changing nature of near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company’s business and profitability.

Research indicates that these estimate revisions are directly correlated with near-term share price momentum. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.

Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Within the past 30 days, our consensus EPS projection has moved 1.36% higher. MS is currently sporting a Zacks Rank of #3 (Hold).

Looking at its valuation, MS is holding a Forward P/E ratio of 13.11. For comparison, its industry has an average Forward P/E of 11.2, which means MS is trading at a premium to the group.

Also, we should mention that MS has a PEG ratio of 2.08. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company’s expected earnings growth rate into account. The Financial – Investment Bank was holding an average PEG ratio of 0.64 at yesterday’s closing price.

The Financial – Investment Bank industry is part of the Finance sector. This industry currently has a Zacks Industry Rank of 101, which puts it in the top 40% of all 250+ industries.

The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $2.4 trillion by 2028 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Recommendations from previous editions of this report have produced gains of +205%, +258% and +477%. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Morgan Stanley (MS): Free Stock Analysis Report
 
To read this article on Zacks.com click here.

You’re reading Entrepreneur United States, an international franchise of Entrepreneur Media. This story originally appeared on Zacks

In the latest trading session, Qorvo (QRVO) closed at $165.33, marking a +0.3% move from the previous day. This change lagged the S&P 500’s 0.83% gain on the day.

Coming into today, shares of the chipmaker had lost 7.79% in the past month. In that same time, the Computer and Technology sector lost 7.26%, while the S&P 500 lost 3.68%.

QRVO will be looking to display strength as it nears its next earnings release. On that day, QRVO is projected to report earnings of $3.25 per share, which would represent year-over-year growth of 33.74%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $1.25 billion, up 17.94% from the year-ago period.

Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of $12.10 per share and revenue of $4.75 billion. These totals would mark changes of +21% and +18.25%, respectively, from last year.

Investors might also notice recent changes to analyst estimates for QRVO. These revisions typically reflect the latest short-term business trends, which can change frequently. As a result, we can interpret positive estimate revisions as a good sign for the company’s business outlook.

Our research shows that these estimate changes are directly correlated with near-term stock prices. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.

The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. QRVO is holding a Zacks Rank of #3 (Hold) right now.

In terms of valuation, QRVO is currently trading at a Forward P/E ratio of 13.62. Its industry sports an average Forward P/E of 13.83, so we one might conclude that QRVO is trading at a discount comparatively.

Meanwhile, QRVO’s PEG ratio is currently 1.07. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company’s expected earnings growth rate. The Semiconductors – Radio Frequency industry currently had an average PEG ratio of 0.86 as of yesterday’s close.

The Semiconductors – Radio Frequency industry is part of the Computer and Technology sector. This industry currently has a Zacks Industry Rank of 240, which puts it in the bottom 6% of all 250+ industries.

The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

You can find more information on all of these metrics, and much more, on Zacks.com.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $2.4 trillion by 2028 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Recommendations from previous editions of this report have produced gains of +205%, +258% and +477%. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Qorvo, Inc. (QRVO): Free Stock Analysis Report
 
To read this article on Zacks.com click here.

You’re reading Entrepreneur United States, an international franchise of Entrepreneur Media. This story originally appeared on Zacks

Okta (OKTA) closed the most recent trading day at $233.96, moving +0.88% from the previous trading session. The stock outpaced the S&P 500’s daily gain of 0.83%.

Heading into today, shares of the cloud identity management company had lost 11.97% over the past month, lagging the Computer and Technology sector’s loss of 7.26% and the S&P 500’s loss of 3.68% in that time.

Wall Street will be looking for positivity from OKTA as it approaches its next earnings report date. The company is expected to report EPS of -$0.23, down 675% from the prior-year quarter. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $327.33 million, up 50.58% from the year-ago period.

Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of -$0.75 per share and revenue of $1.25 billion. These totals would mark changes of -781.82% and +49.55%, respectively, from last year.

Investors should also note any recent changes to analyst estimates for OKTA. Recent revisions tend to reflect the latest near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company’s business outlook.

Based on our research, we believe these estimate revisions are directly related to near-team stock moves. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.

The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. OKTA is currently a Zacks Rank #5 (Strong Sell).

The Internet – Software and Services industry is part of the Computer and Technology sector. This industry currently has a Zacks Industry Rank of 237, which puts it in the bottom 7% of all 250+ industries.

The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $2.4 trillion by 2028 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Recommendations from previous editions of this report have produced gains of +205%, +258% and +477%. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Okta, Inc. (OKTA): Free Stock Analysis Report
 
To read this article on Zacks.com click here.

You’re reading Entrepreneur United States, an international franchise of Entrepreneur Media. This story originally appeared on Zacks

QuantumScape Corporation (QS) closed at $22.82 in the latest trading session, marking a +1.51% move from the prior day. This move outpaced the S&P 500’s daily gain of 0.83%.

Coming into today, shares of the company had gained 8.39% in the past month. In that same time, the Auto-Tires-Trucks sector lost 3.1%, while the S&P 500 lost 3.68%.

Investors will be hoping for strength from QS as it approaches its next earnings release.

Investors should also note any recent changes to analyst estimates for QS. These revisions help to show the ever-changing nature of near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company’s business and profitability.

Our research shows that these estimate changes are directly correlated with near-term stock prices. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.

The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. QS is holding a Zacks Rank of #3 (Hold) right now.

The Automotive – Original Equipment industry is part of the Auto-Tires-Trucks sector. This industry currently has a Zacks Industry Rank of 211, which puts it in the bottom 17% of all 250+ industries.

The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

You can find more information on all of these metrics, and much more, on Zacks.com.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $2.4 trillion by 2028 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Recommendations from previous editions of this report have produced gains of +205%, +258% and +477%. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
QuantumScape Corporation (QS): Free Stock Analysis Report
 
To read this article on Zacks.com click here.